no image available Dickens & Co. "A New Hope for Recurring Lung Cancer: The Celecoxib-Docetaxel Combination" "Unleashing the Power of COX-2 Inhibition in Non-Small Cell Lung Cancer's Darkest Hour" Price: 26.00€